Global Clinical Trial Imaging Market Insights Report 2019 – Cardiovascular Imaging Technologies, ICON Public Limited Company, Intrinsic Imaging, LLC, IXICO, PLC, PAREXEL International Corporation

databridgemarketresearch

Global Clinical Trial Imaging Market is expected to rise gradually to an estimated value of USD 1579.72 million by 2026, registering a CAGR of 7.5% in the forecast period of 2019-2026 with the annual sales of USD 885.75 million in 2018.

Get Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-trial-imaging-market

Global Clinical Trial Imaging Market By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography), Products {Services (Operational Imaging Services, Read Analysis Services, System and Technical Support Services, Trial Design Consulting Services)& Software}, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic & Government Research Institutes), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Few of the major competitors currently working in the clinical trial imaging market are BioClinica, Inc., Biomedical Systems, Cardiovascular Imaging Technologies, ICON Public Limited Company, Intrinsic Imaging, LLC, IXICO, PLC, PAREXEL International Corporation, Radiant Sage, LLC, BioTelemetric, Inc.,  WorldCare Clinical, LLC, Clarity Pharmaceuticals, Quotient Sciences, VirtualScopics, Prism Clinical Imaging, Medical Metrics, Mint Medical GmbH, Image Core Lab, BANOOK GROUP, Intrinsic Imaging, LLC,  ERT Clinical and few among others.

Key Developments in the Market:

  • On 21stMarch 2018, Intrinsic Imaging, LLC, a FDA and ISO certified medical imaging that provides services in support of Phase I-IV clinical trials completed a very large 12,480 read pivotal oncology clinical trial. Such operational excellence and efficiency in conducting clinical trials will help to grow the market.
  • On 28thJanuary 2019, BioTelemetry, Inc., the leading remote and wireless medical technology company has signed a merger agreement with Geneva Healthcare, Inc. Company developed a cloud based platform that monitors all the physician’s patients. By acquiring the company, BioTelemetry, Inc. can utilize the valuable asset for clinical trial imaging market and achieve greater heights.

Market Definition: Global Clinical Trial Imaging Market

Clinical trial is the vital part of drug developing process. Imaging has been the emerging market in clinical and non-clinical fields. Medical imaging is playing a significant role in clinical trials for more effective and accurate results. Clinical imaging is used to prevent, detect, treat and manage various diseases or medical conditions.

Market Drivers

  • Increasing number of contract research organization
  • Growth in geriatric population with chronic diseases
  • Rise in R&D investments
  • Emergence of pharmaceutical and biotechnology industries

Market Restraints

  • High price if imaging hampers the market
  • High implementation barriers may restrain the growth of the market.

Order a Copy of This Research Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-clinical-trial-imaging-market

Segmentation: Global Clinical Trial Imaging Market

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-Ray
  • Echocardiography

By Products

  • Services
    • Operational Imaging Services
    • Read Analysis Services
    • System and Technical Support Services
    • Trial Design Consulting Services
  • Software

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Academic & Government Research Institutes

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Competitive Analysis:

Global clinical trial imaging market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of clinical trial imaging market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global clinical trial imaging market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Get Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-clinical-trial-imaging-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]